Novo’s investigational obesity and diabetes drug CagriSema reduces ‘food noise’ and shows benefits in organ and bone health – EASD 2026

4 reports from 4 outlets in 1 language · first reported 2026-09-30 12:30 UTC · updated 2026-09-30 16:04 UTC · JSON

Reports

1. Novo Nordisk CagriSema Cuts "Food Noise", Shows Organ And Bone Health Benefitsrttnews.com · en · 2026-09-30 16:04 UTC
2. Novo's investigational obesity and diabetes drug CagriSema reduces 'food noise' and shows benefits in organ and bone health – EASD 2026 | Company Announcementinvestegate.co.uk · en · 2026-09-30 12:52 UTC
3. Novo's investigational obesity and diabetes drug CagriSema reduces 'food noise' and shows benefits in organ and bone health - EASD 2026manilatimes.net · en · 2026-09-30 12:40 UTC
4. Novo’s investigational obesity and diabetes drug CagriSema reduces ‘food noise’ and shows benefits in organ and bone health – EASD 2026GlobeNewswire — public companies · en · 2026-09-30 12:30 UTC